熱門資訊> 正文
Calliditas Therapeutics将从斯德哥尔摩纳斯达克退市
2024-09-16 22:45
- Calliditas Therapeutics AB (NASDAQ:CALT) said on Monday that Nasdaq Stockholm has decided the company will be delisted from Nasdaq Stockholm.
- The last day of trading in the share will be on Thursday, October 10, 2024.
More on Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript
- Calliditas's Kinpegyo gets EU approval, setanaxib study meets endpoint
- Seeking Alpha’s Quant Rating on Calliditas Therapeutics
- Historical earnings data for Calliditas Therapeutics
- Financial information for Calliditas Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
